Cravath represented the borrower, HLS Therapeutics Inc., in connection with the arrangement of its $125 million credit facilities provided by JPMorgan Chase Bank, N.A., to be…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
